H
Harvest
Tax-loss replacement research
AMGN
Amgen Inc.
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for AMGN

Among the 28 Biotechnology peers screened, BIIB (Biogen Inc.) has tracked AMGN most closely over the past year, with a return correlation of 0.50. The strongest fund stand-in is PPH (VanEck Pharma ETF) at 0.70 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
BIIBBiogen Inc.Biotechnology0.500.510.420.40
VRTXVertex PharmaceuticalsBiotechnology0.490.380.380.44
INCYIncyteBiotechnology0.480.370.350.38
REGNRegeneron PharmaceuticalsBiotechnology0.480.410.390.44
GILDGilead SciencesBiotechnology0.470.420.450.49
EXELExelixisBiotechnology0.370.200.210.30
HALOHalozymeBiotechnology0.350.290.290.32
ALNYAlnylam PharmaceuticalsBiotechnology0.320.290.240.27
FTREFortreaBiotechnology0.310.280.28
BMRNBioMarin PharmaceuticalBiotechnology0.290.320.290.37
NBIXNeurocrine BiosciencesBiotechnology0.290.250.220.30
VIRVir Biotechnology, Inc.Biotechnology0.270.260.220.12
ROIVRoivant SciencesBiotechnology0.260.250.14
RGENRepligenBiotechnology0.250.230.190.27
XNCRXencor IncBiotechnology0.240.270.280.34
MRNAModerna Inc.Biotechnology0.230.210.190.17
ADMAADMA Biologics, Inc.Biotechnology0.200.170.170.13
UTHRUnited TherapeuticsBiotechnology0.190.260.280.31
SRPTSarepta TherapeuticsBiotechnology0.190.190.190.21
VCELVericelBiotechnology0.190.230.220.22
RCUSArcus Biosciences, Inc.Biotechnology0.190.220.200.23
TGTXTG Therapeutics, Inc.Biotechnology0.190.180.140.21
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.180.160.170.28
CYTKCytokineticsBiotechnology0.160.190.180.25
KRYSKrystal BiotechBiotechnology0.150.190.150.20
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.140.150.17
ARWRArrowhead PharmaceuticalsBiotechnology0.140.230.220.23
PTGXProtagonist Therapeutics, Inc.Biotechnology0.130.190.090.10
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.700.610.580.63
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.690.640.590.66
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.680.640.590.67
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.680.630.580.66
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.670.630.580.66
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.650.580.550.62
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.620.610.520.61
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.400.420.350.45
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.380.450.420.51
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.310.330.330.46
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.270.300.270.35
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.180.290.330.45
NEXT STEPS

Harvesting a loss in AMGN?

RELATED

Replacement research for AMGN's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.